Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | GATAD2B |
| Upstream (Parents) |
|---|
| (<<) EN1 → GATAD2B |
| (<<) KLF5 → GATAD2B |
| (<<) E2F7 → GATAD2B |
| (<<) NFIX → GATAD2B |
| (<<) XBP1 → GATAD2B |
| (<<) CREB3L1 → GATAD2B |
| (<<) KDM5A → GATAD2B |
| (<<) ZNF397 → GATAD2B |
| (<<) HIC1 → GATAD2B |
| (<<) ATF6 → GATAD2B |
| Downstream (Children) |
|---|
| GATAD2B → SOX9 (>>) |
| GATAD2B → IRX4 (>>) |
| GATAD2B → DLX6 (>>) |
| GATAD2B → ASCL2 (>>) |
| GATAD2B → LASS6 (>>) |
| GATAD2B → THRB (>>) |
| GATAD2B → NKX3-1 (>>) |
| GATAD2B → LMO4 (>>) |
| GATAD2B → HR (>>) |
| GATAD2B → ZNF135 (>>) |
| GATAD2B → SMAD4 (>>) |
| GATAD2B → NFYA (>>) |
| GATAD2B → PPARG (>>) |
| GATAD2B → POU4F1 (>>) |
| GATAD2B → FUBP1 (>>) |
| GATAD2B → VDR (>>) |
| GATAD2B → BCL3 (>>) |
| GATAD2B → TSHZ1 (>>) |
| GATAD2B → ZNF140 (>>) |
| GATAD2B → SMAD2 (>>) |
